If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email email@example.com
Authors: Jiao, J.; Xiang, H.; Liao, Q.
Source: Current Medicinal Chemistry, Volume 17, Number 30, October 2010, pp. 3476-3487(12)
Publisher: Bentham Science Publishers
Keywords: (EGFR) HER-2; Aromatase (AR); Aromatase inhibitors; C19 androgenic; COX-2; CYP19; Dual Aromatase-Sulfatase Inhibitors; Estrogen receptor; Estrogen-dependent breast cancer; Estrone 3-sulfamate (EMATE); Isoflavones; Nimesulide Analogues; Nonsteroidal Aromatase Inhibitors; PGE2; YM511; aminoglutethimide; aromatase; aromatase (AR); aromatase inhibitors; breast adipose stromal; celecoxib; cellular transformation; endocrine therapy; flavanone; glycosylated cytochrome P450; granulosa; imidazolic; inflammatory cytokines; inhibitory potency; letrozole, anastrozole; liquiritigenin; long-term tamoxifen treatment; luteal cells; mammary tumors; multienzymatic complex; nonsteroida; nonsteroidal; oncogenesis; ovarian granulosa cells; peripheral tissues; postmenopausal women; prostaglandin E2 (PGE2); prostate cancer; pyridinecontaining (E)-isomer; therapeutic agents; tolerability; traditional Chinese medicine
Document Type: Research Article
Affiliations: Medicinal Chemistry, College of Pharmacy, China Pharmaceutical University, 24,Tong Jia Xiang Road, 210009, Nanjing, Jiangsu, P.R. China.
Publication date: October 1, 2010